The AAPP membership has elected three officers to serve on the 2023-2025 Board of Directors. Assuming their offices effective July 1, 2023, will be Drs. Jolene Bostwick, Michelle Geier, and Kristina Reinstatler. These 3 new members will join Drs. Ben Chavez, Cindy Gutierrez, Suzanne Harris, Amy Werremeyer and Andrew Williams on the Board for 2023-2024.
 |
Incoming President-Elect Dr. Michelle Geier, PharmD, BCPP
Dr. Michelle Geier graduated from University of Washington School of Pharmacy and completed a pharmacy practice PGY1 residency at the VA Puget Sound and a psychiatric pharmacy PGY2 residency at University of California San Francisco/San Francisco Department of Public Health. She began working with the San Francisco Department of Public Health Behavioral Health Service (SFDPH BHS) as a psychiatric and substance use disorders clinical pharmacist in 2012. In her current practice, she provides ambulatory care psychiatric services in a public health specialty mental health clinic. Some of the projects she has worked on include naloxone prescribing by pharmacists, deprescribing sedative-hypnotics and initiating buprenorphine in high risk areas with transitions to outpatient (including jail, inpatient and the emergency department).
|
 |
Incoming Member-at-Large Dr. Jolene Bostwick, PharmD, BCPS, BCPP Dr. Bostwick graduated in 2004 from the University of Michigan College of Pharmacy and completed a specialty residency in psychiatric pharmacy with Kaiser Permanente in Denver, CO. She subsequently practiced as a “front line” psychiatric pharmacist for 15 years, developing pharmacy services in inpatient and outpatient psychiatry before transitioning into her current administrative role in February 2020. |
 |
Incoming Member-at-Large Dr. Kristina Reinstatler, PharmD, MBA, BCPP Dr. Reinstatler graduated from the University of Cincinnati and completed a residency at the Chillicothe VA and worked part time until she was hired as a Clinical Staff Pharmacist at University of Cincinnati Medical Center. She earned her BCPP 2012 and transitioned to a Clinical Pharmacy Specialist, which grew to encompass psychiatry and addiction sciences. |